The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Se­qens ma­jor­i­ty own­er look­ing to sell API mak­er amid record-high run in health­care val­u­a­tions: re­port

5 years ago
Deals

Mer­ck KGaA ex­pands its deal with Pfiz­er/BioN­Tech with an eye on a key vac­cine man­u­fac­tur­ing bot­tle­neck

5 years ago
Coronavirus

FDA cites litany of er­rors at Lon­za Hous­ton plant at the cen­ter of Bris­tol My­ers CVR de­ba­cle

5 years ago
FDA+

Rapid CD­MO growth marks a start to End­points Man­u­fac­tur­ing's first re­port — here's what to ex­pect from our cov­er­age

5 years ago

Re­call re­port: Apo­tex re­calls 2 batch­es of blood-thin­ner in­jec­tion af­ter sy­ringe mis­la­bel­ing sna­fu

5 years ago
FDA+

Glax­o­SmithK­line dou­bles down on Cure­Vac's mR­NA tech, bets $180M on the hunt for next-gen vac­cine

5 years ago
Deals
Coronavirus

WuXi STA snaps up Bris­tol My­ers Squibb fa­cil­i­ty, plants feet in Eu­ro­pean CD­MO mar­ket­place

5 years ago
Deals

Ex­clu­sive: Johns Hop­kins pro­fes­sor and biotech col­leagues tout new tech to test Covid-19 vac­cine re­sponse

5 years ago
Coronavirus

Ther­mo Fish­er plat­form seeks to ex­pe­dite donor cell cul­ti­va­tion for al­lo­gene­ic cell ther­a­pies

5 years ago

Lon­za look­ing to build on 'd­if­fer­en­ti­at­ed ad­van­tage' in Covid-19, CD­MO mar­ket­place in 2021

5 years ago
Pharma

Flush with cash to change the gener­ics sup­ply chain, Civi­ca Rx looks to break ground on first in-house man­u­fac­tur­ing site

5 years ago

North­way Biotech sets up shop in Boston hub, look­ing to court more cus­tomers with bi­o­log­ics-fo­cused plant

5 years ago

Lon­za hits the ex­it on gel and liq­uid cap­sules, of­fload­ing 2 pro­duc­tion sites to NextPhar­ma

5 years ago
Deals

Cog­nate dou­bles man­u­fac­tur­ing ca­pac­i­ties in Mem­phis, Eu­rope, as de­mand for cell and gene ther­a­pies sky­rock­ets

5 years ago
Cell/Gene Tx

Look­ing to build in red-hot vi­ral vec­tor space, Ther­mo Fish­er inks $878M deal for Bel­gian man­u­fac­tur­er's 2 plants

5 years ago
Deals

Fu­ji­film dou­bles down on Boston foothold, rent­ing some ma­jor legroom to chase cell and gene ther­a­pies

5 years ago
Financing

Acor­da of­floads man­u­fac­tur­ing op­er­a­tions to Catal­ent for $70M amid lat­est re­struc­tur­ing to keep the ship afloat

5 years ago
Deals

Adap­ti­m­mune 'ready for prime­time' as it pre­pares to launch T cell ther­a­py for sar­co­ma, CEO Adri­an Raw­cliffe says

5 years ago
Cell/Gene Tx

Abzena plots 6th bi­o­log­ics plant as de­mand for mam­malian cell-line pro­duc­tion con­tin­ues to grow

5 years ago

Once aim­ing to dou­ble on­col­o­gy pipeline, Servier's US branch touts rapid pace in build­ing its foothold in the space

5 years ago

Boehringer In­gel­heim per­ma­nent­ly shelves pro­duc­tion of cloni­dine, cit­ing ear­li­er re­call and mar­ket com­peti­tors

5 years ago
FDA+

Af­ter ear­ly hic­cups in man­u­fac­tur­ing, Ad­verum out­lines plans for com­mer­cial gene ther­a­py plant in North Car­oli­na hub

5 years ago

Mer­ck KGaA snaps up Ger­man CD­MO in boost to mR­NA port­fo­lio — in­clud­ing for Covid-19

5 years ago
Deals

Mod­er­na inks deal for over­seas Covid-19 vac­cine fin­ish­ing work as Eu­ro­pean ap­proval hangs in bal­ance

5 years ago
Coronavirus
First page Previous page 7677787980 Next page Last page
A service from the Financial Times